Literature DB >> 23811324

Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.

Eino J H Palin1, Anders Paetau, Anu Suomalainen.   

Abstract

Genetic evidence from recessively inherited Parkinson's disease has indicated a clear causative role for mitochondrial dysfunction in Parkinson's disease. This role has long been discussed based on findings that toxic inhibition of mitochondrial respiratory complex I caused parkinsonism and that tissues of patients with Parkinson's disease show complex I deficiency. Disorders of mitochondrial DNA maintenance are a common cause of inherited neurodegenerative disorders, and lead to mitochondrial DNA deletions or depletion and respiratory chain defect, including complex I deficiency. However, parkinsonism associates typically with defects of catalytic domain of mitochondrial DNA polymerase gamma. Surprisingly, however, not all mutations affecting DNA polymerase gamma manifest as parkinsonism, but, for example, spacer region mutations lead to spinocerebellar ataxia and/or severe epilepsy. Furthermore, defective Twinkle helicase, a close functional companion of DNA polymerase gamma in mitochondrial DNA replication, results in infantile-onset spinocerebellar ataxia, epilepsy or adult-onset mitochondrial myopathy, but not typically parkinsonism. Here we sought for clues for this specificity in the neurological manifestations of mitochondrial DNA maintenance disorders by studying mesencephalic neuropathology of patients with DNA polymerase gamma or Twinkle defects, with or without parkinsonism. We show here that all patients with mitochondrial DNA maintenance disorders had neuronopathy in substantia nigra, most severe in DNA polymerase gamma-associated parkinsonism. The oculomotor nucleus was also affected, but less severely. In substantia nigra, all patients had a considerable decrease of respiratory chain complex I, but other respiratory chain enzymes were not affected. Complex I deficiency did not correlate with parkinsonism, age, affected gene or inheritance. We conclude that the cell number in substantia nigra correlated well with parkinsonism in DNA polymerase gamma and Twinkle defects. However, complex I defect is a general consequence of mitochondrial DNA maintenance defects, and does not explain manifestation of parkinsonism or degree of mesencephalic cell death in patients with mitochondrial DNA maintenance disorders.

Entities:  

Keywords:  ataxia; mitochondrial DNA; mitochondrial disorders; mitochondrial dysfunction; parkinsonism

Mesh:

Substances:

Year:  2013        PMID: 23811324     DOI: 10.1093/brain/awt160

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  23 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

Review 2.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

Review 3.  NAD+ in Brain Aging and Neurodegenerative Disorders.

Authors:  Sofie Lautrup; David A Sinclair; Mark P Mattson; Evandro F Fang
Journal:  Cell Metab       Date:  2019-10-01       Impact factor: 27.287

4.  Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.

Authors:  Riikka H Hämäläinen; Tuula Manninen; Hanna Koivumäki; Mikhail Kislin; Timo Otonkoski; Anu Suomalainen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

5.  Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.

Authors:  Hyung-Wook Kim; Won-Seok Choi; Noah Sorscher; Hyung Joon Park; François Tronche; Richard D Palmiter; Zhengui Xia
Journal:  Neurobiol Aging       Date:  2015-05-16       Impact factor: 4.673

Review 6.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 7.  Protecting the mitochondrial powerhouse.

Authors:  Morten Scheibye-Knudsen; Evandro F Fang; Deborah L Croteau; David M Wilson; Vilhelm A Bohr
Journal:  Trends Cell Biol       Date:  2014-12-11       Impact factor: 20.808

8.  One complex world of mitochondrial parkinsonism.

Authors:  Patrick F Chinnery
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

9.  mtDNA Mutagenesis Disrupts Pluripotent Stem Cell Function by Altering Redox Signaling.

Authors:  Riikka H Hämäläinen; Kati J Ahlqvist; Pekka Ellonen; Maija Lepistö; Angela Logan; Timo Otonkoski; Michael P Murphy; Anu Suomalainen
Journal:  Cell Rep       Date:  2015-05-28       Impact factor: 9.423

Review 10.  Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus.

Authors:  Thomas Paß; Rudolf J Wiesner; David Pla-Martín
Journal:  Front Mol Biosci       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.